The evolution of therapeutic modalities drives the adoption of single-use technologies.

Review of SUT Adoption in Biopharma Manufacturing

Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.

Why Are Pharmaceutical Companies Reluctant to Adopt Cloud Technologies?

Given the criticality of fill/finish processes, it is clear that automation is the next technological step.

 Automating the Future of Fill/Finish

Topic

Articles

The Alliance will receive the NSF Regional Innovation Engines Development Award and $1 million in funding.

Alliance for Building Better Medicine Receives NSF Award

The facility producer’s new innovation hub will offer manufacturing, life sciences, and infrastructure services.

Jacobs Announces Innovation Hub in Denmark

Chris Spivey is director of Industry Relations and Strategic Partnership, MJH Life Sciences.

Videos

Cellares CEO Fabian Gerlinghaus shares how an automated, closed-production platform with a small footprint can dramatically impact cost savings and scalability for cell and gene therapies.

Cellares Innovates With Automated Cell and Gene Therapy Platform

Webcasts

Webinar Date/Time: Tue, Mar 26, 2024 11:00 AM EDT




  Microdosing: A Powder-in-Capsule Technology Pathway from Development to Commercialization

Webinar Date/Time: Friday, April 5, 2024 at 11amEDT | 10am CDT | 8am PDT




Transferring Energy to Hot Melt Extrusions

 in 2014, Adam Goulder has over 30 years' experience within the maintenance engineering and asset management sectors including Pharmaceutical and Medical Devices manufacturing. As Head of Project Management and a Principal Consultant Adam oversees the management and implementation of enterprise asset management solutions to a wide range of organisations across the Pharmaceutical, Medical Devices, Healthcare, Logistics, Facilities Management, Utilities, Oil & Gas, and Transportation sectors. Adam is a Chartered Engineer, holds an MSc in Maintenance Engineering and Asset Management from the University of Manchester and is a member of the International Society of Pharmaceutical Engineers.

Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Automating the Future of Fill/Finish

Cheryl Barton is director of PharmaVision, 

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

The partnership will allow for both companies to provide end-to-end biopharmaceutical manufacturing solutions.

BioCina and NovaCina to Partner on Drug Substance and Product Solutions for Biologics

Feliza Mirasol is the science editor for 

CordenPharma’s new starter kits are designed to enable effective formulation in the development of mRNA-based therapeutics.